Chemotherapy in the treatment and control of leishmaniasis
J Alvar, S Croft, P Olliaro - Advances in parasitology, 2006 - Elsevier
Drugs remain the most important tool for the treatment and control of both visceral and
cutaneous leishmaniasis. Although there have been several advances in the past decade,
with the introduction of new therapies by liposomal amphotericin, oral miltefosine and
paromomycin (PM), these are not ideal drugs, and improved shorter duration, less toxic and
cheaper therapies are required. Treatments for complex forms of leishmaniasis and HIV co-
infections are inadequate. In addition, full deployment of drugs in treatment and control …
cutaneous leishmaniasis. Although there have been several advances in the past decade,
with the introduction of new therapies by liposomal amphotericin, oral miltefosine and
paromomycin (PM), these are not ideal drugs, and improved shorter duration, less toxic and
cheaper therapies are required. Treatments for complex forms of leishmaniasis and HIV co-
infections are inadequate. In addition, full deployment of drugs in treatment and control …